Perioperative management of adult diabetic patients. The role of the diabetologist.

Gaëlle Cheisson, Sophie Jacqueminet, Emmanuel Cosson, Carole Ichai, Anne-Marie Leguerrier, Bogdan Nicolescu-Catargi, Alexandre Ouattara, Igor Tauveron, Paul Valensi, Dan Benhamou

Journal: Anaesthesia, critical care & pain medicine 2019;37 Suppl 1():S37-S38

PMID: 29317312

Free Full Text on Elsevier Science View on PubMed

Abstract

A patient should be referred to a diabetologist perioperatively in several circumstances: preoperative recognition of a previously unknown diabetes or detection of glycaemic imbalance (HbA1c <5% or >8%); during hospitalisation, recognition of a previously unknown diabetes, persisting glycaemic imbalance despite treatment or difficulty resuming previously used chronic treatment; postoperatively and after discharge from hospital, for all diabetic patients in whom HbA1c is >8%.

Address: Anaesthesia and intensive care department, hôpitaux universitaires Paris-Sud, AP-HP, hôpital de Bicêtre, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France.; Heart metabolism and nutrition institute, AP-HP, hôpital de la Pitié-Salpêtrière, 75013 Paris, France; Department of diabetes and metabolic diseases, hôpital de la Pitié-Salpêtrière, 75013 Paris, France.; CRNH-IdF, CINFO, endocrinology-diabetology-nutrition department, hôpital Jean-Verdier, AP-HP, université Paris 13, Sorbonne Paris Cité, 93140 Bondy, France; Inserm, UMR U1153, U1125 INRA/CNAM, Sorbonne Paris Cité, université Paris 13, 93000 Bobigny, France.; Polyvalent intensive care department, hôpital Pasteur 2, CHU de Nice, 30, voie Romaine, 06001 Nice cedex 1, France; IRCAN (Inserm U1081, CNRS UMR 7284), University Hospital of Nice, 06001 Nice, France.; Endocrinology and diabetology department, CHU de Rennes, CHU hôpital Sud, 16, boulevard de Bulgarie, 35056 Rennes, France.; Metabolic diseases and endocrinology department, hôpital Saint-André, CHU de Bordeaux, 1, rue Jean-Burguet, 33000 Bordeaux, France.; CHU de Bordeaux, department of anaesthesia and critical care II, Magellan medico-surgical center, 33000 Bordeaux, France; Inserm, UMR 1034, Université Bordeaux, biology of cardiovascular diseases, 33600 Pessac, France.; Endocrinology and diabetology department, CHU de Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France; UFR médecine, université Clermont-Auvergne, 28, place Henri-Dunant, 63000 Clermont-Ferrand, France; Inserm U1103, UMR CNRS 6293, génétique reproduction et développement, université Clermont-Auvergne, 63170 Aubière, France; Endocrinology and diabetology department, CHU G.-Montpied BP 69, 63003 Clermont-Ferrand, France.; CRNH-IdF, CINFO, endocrinology-diabetology-nutrition department, hôpital Jean-Verdier, AP-HP, université Paris 13, Sorbonne Paris Cité, 93140 Bondy, France.; Anaesthesia and intensive care department, hôpitaux universitaires Paris-Sud, AP-HP, hôpital de Bicêtre, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France. Electronic address: [email protected].

DOI: 10.1016/j.accpm.2017.10.009